These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 19861905

  • 1. Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers.
    Pastorino U, Landoni C, Marchianò A, Calabrò E, Sozzi G, Miceli R, Picchio M, Mariani L, Messa C, Fazio F.
    J Thorac Oncol; 2009 Nov; 4(11):1352-6. PubMed ID: 19861905
    [Abstract] [Full Text] [Related]

  • 2. Limited Prognostic Value of SUV max Measured by F-18 FDG PET/CT in Newly Diagnosed Small Cell Lung Cancer Patients.
    Kim SJ, Chang S.
    Oncol Res Treat; 2015 Nov; 38(11):577-85. PubMed ID: 26599271
    [Abstract] [Full Text] [Related]

  • 3. Standard uptake value predicts survival in non-small cell lung cancer.
    Okereke IC, Gangadharan SP, Kent MS, Nicotera SP, Shen C, DeCamp MM.
    Ann Thorac Surg; 2009 Sep; 88(3):911-5; discussion 915-6. PubMed ID: 19699919
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP.
    Biomed Mater Eng; 2014 Sep; 24(6):3091-103. PubMed ID: 25227018
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
    Liao S, Penney BC, Zhang H, Suzuki K, Pu Y.
    Acad Radiol; 2012 Jan; 19(1):69-77. PubMed ID: 22142679
    [Abstract] [Full Text] [Related]

  • 6. Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer.
    Sachs S, Bilfinger TV, Komaroff E, Franceschi D.
    Clin Lung Cancer; 2005 Mar; 6(5):310-3. PubMed ID: 15845183
    [Abstract] [Full Text] [Related]

  • 7. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
    Zytoon AA, Murakami K, El-Kholy MR, El-Shorbagy E, Ebied O.
    Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387
    [Abstract] [Full Text] [Related]

  • 8. Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection.
    Downey RJ, Akhurst T, Gonen M, Vincent A, Bains MS, Larson S, Rusch V.
    J Clin Oncol; 2004 Aug 15; 22(16):3255-60. PubMed ID: 15310769
    [Abstract] [Full Text] [Related]

  • 9. FDG uptake heterogeneity evaluated by fractal analysis improves the differential diagnosis of pulmonary nodules.
    Miwa K, Inubushi M, Wagatsuma K, Nagao M, Murata T, Koyama M, Koizumi M, Sasaki M.
    Eur J Radiol; 2014 Apr 15; 83(4):715-9. PubMed ID: 24418285
    [Abstract] [Full Text] [Related]

  • 10. Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours.
    Krüger S, Buck AK, Blumstein NM, Pauls S, Schelzig H, Kropf C, Schumann C, Mottaghy FM, Hombach V, Reske SN.
    J Intern Med; 2006 Dec 15; 260(6):545-50. PubMed ID: 17116005
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of 18F-FDG standard uptake value by integrated PET/CT in the staging of malignant pleural mesothelioma.
    Genestreti G, Moretti A, Piciucchi S, Tiseo M, Bersanelli M, Scarlattei M, Scarpi E, Dubini A, Matteucci F, Sanna S.
    Technol Cancer Res Treat; 2012 Apr 15; 11(2):163-7. PubMed ID: 22335410
    [Abstract] [Full Text] [Related]

  • 12. ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography in mucinous adenocarcinoma.
    Murakami S, Saito H, Karino F, Kondo T, Oshita F, Ito H, Nakayama H, Yokose T, Yamada K.
    Eur J Radiol; 2013 Nov 15; 82(11):e721-5. PubMed ID: 23988690
    [Abstract] [Full Text] [Related]

  • 13. Usefulness of FDG-PET/CT in the detection of pancreatic metastases from lung cancer.
    Sato M, Okumura T, Kaito K, Kiyoshima M, Asato Y, Uchiumi K, Iijima H, Hashimoto I, Kaburagi T, Amemiya R.
    Ann Nucl Med; 2009 Jan 15; 23(1):49-57. PubMed ID: 19205838
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer.
    Park SY, Cho A, Yu WS, Lee CY, Lee JG, Kim DJ, Chung KY.
    J Nucl Med; 2015 Jan 15; 56(1):45-9. PubMed ID: 25525185
    [Abstract] [Full Text] [Related]

  • 15. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX, Cheng J, Xu WG, Dai D, Song XY, Ma WC, Zhu L, Zhu X.
    Zhonghua Zhong Liu Za Zhi; 2012 May 15; 34(5):364-8. PubMed ID: 22883458
    [Abstract] [Full Text] [Related]

  • 16. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
    Heusch P, Buchbender C, Köhler J, Nensa F, Beiderwellen K, Kühl H, Lanzman RS, Wittsack HJ, Gomez B, Gauler T, Schuler M, Forsting M, Bockisch A, Antoch G, Heusner TA.
    Rofo; 2013 Nov 15; 185(11):1056-62. PubMed ID: 23860802
    [Abstract] [Full Text] [Related]

  • 17. Fluorodeoxyglucose uptake of primary non-small cell lung cancer at positron emission tomography: new contrary data on prognostic role.
    Vesselle H, Freeman JD, Wiens L, Stern J, Nguyen HQ, Hawes SE, Bastian P, Salskov A, Vallières E, Wood DE.
    Clin Cancer Res; 2007 Jun 01; 13(11):3255-63. PubMed ID: 17545531
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer.
    Hellwig D, Gröschel A, Graeter TP, Hellwig AP, Nestle U, Schäfers HJ, Sybrecht GW, Kirsch CM.
    Eur J Nucl Med Mol Imaging; 2006 Jan 01; 33(1):13-21. PubMed ID: 16151765
    [Abstract] [Full Text] [Related]

  • 19. (18)F-fluorodeoxyglucose positron emission tomography versus computed tomography in predicting histopathological response to epidermal growth factor receptor-tyrosine kinase inhibitor treatment in resectable non-small cell lung cancer.
    van Gool MH, Aukema TS, Schaake EE, Rijna H, Codrington HE, Valdés Olmos RA, Teertstra HJ, van Pel R, Burgers SA, van Tinteren H, Klomp HM.
    Ann Surg Oncol; 2014 Sep 01; 21(9):2831-7. PubMed ID: 24845729
    [Abstract] [Full Text] [Related]

  • 20. Role of 2-[18F] fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in the post-therapy surveillance of breast cancer.
    Chang HT, Hu C, Chiu YL, Peng NJ, Liu RS.
    PLoS One; 2014 Sep 01; 9(12):e115127. PubMed ID: 25517451
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.